Results 21 to 30 of about 2,247,202 (202)

Left Ventricular Hypertrophy and Hypertension

open access: yesClinical and Experimental Hypertension, 1993
The level of left ventricular (LV) mass as measured by echocardiography or other techniques in hypertensive patients reflects the integrated effects of the level of arterial pressure, the concomitant volume load imposed on the heart, and of alterations in arterial waveform morphology as well as of body size and non-hemodynamic variables.
Devereux RB   +5 more
openaire   +3 more sources

Massive Left Ventricular Hypertrophy With Acromegaly

open access: yes, 2023
Acromegaly—a rare endocrine disorder—results when a growth hormone–secreting somatotroph pituitary adenoma leads to increased insulin-like growth factor 1 production. Acromegaly is known to cause left ventricular hypertrophy.
Blair Tilkens, DO   +16 more
core   +2 more sources

Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications

open access: yesInternational Journal of Hypertension, 2011
Left ventricular hypertrophy is a maladaptive response to chronic pressure overload and an important risk factor for atrial fibrillation, diastolic heart failure, systolic heart failure, and sudden death in patients with hypertension.
Richard E. Katholi, Daniel M. Couri
doaj   +1 more source

Obese subjects show sex-specific differences in right ventricular hypertrophy [PDF]

open access: yes, 2015
As right ventricular (RV) remodeling in obesity remains underinvestigated, and the impact of left ventricular (LV) diastolic dysfunction on RV hypertrophy is unknown, we aimed to investigate whether (1) sex-specific patterns of RV remodeling exist in ...
Francis, JM   +10 more
core   +1 more source

Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study.

open access: yesPLoS ONE, 2014
ObjectiveTo determine the association between left ventricular hypertrophy and insulin resistance in Gambians.DesignCross-sectional study.SettingOutpatient clinics of Royal Victoria Teaching Hospital and Medical Research Council Laboratories in Banjul ...
Bernard Cudjoe Nkum   +3 more
doaj   +1 more source

Sostoyanie serdtsa po dannym ekhokardiografiiu lits s ozhireniem, manifestirovavshimv pubertatnyy period

open access: yesОжирение и метаболизм, 2011
47 male patients were included in this study: the group of 17 adolescents with puberty-onset obesity (aged 19,7±0,37 years), the group of 20 adults with puberty-onset obesity (aged 32,25±0,96 years), 10 gender-matched controls (aged 20,8±0,25 years). All

doaj   +1 more source

Comparative evaluation of left ventricular mass regression after aortic valve replacement: a prospective randomized analysis [PDF]

open access: yes, 2011
Background: We assessed the hemodynamic performance of various prostheses and the clinical outcomes after aortic valve replacement, in different age groups.
Wood Jeffrey P   +11 more
core   +2 more sources

Biomarkers of ventricular remodelling in African hypertensives. [PDF]

open access: yes, 2013
Includes abstract.Includes bibliographical references.There is substantial evidence that the burden of hypertension, hypertension with left ventricular hypertrophy and hypertensive heart failure is very enormous in sub-Saharan Africa.
Dike, Ojji
core   +1 more source

The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis

open access: yesIndian Heart Journal, 2019
Objectives: The aim of the study was to evaluate the correlation between left ventricular hypertrophy and the gene polymorphism of angiotensin-converting enzyme (ACE) intron deletion (I/D) and ACE G2350A.
Jonny Karunia Fajar   +5 more
doaj   +1 more source

The role of urate and xanthine oxidase in vascular oxidative stress:Future directions [PDF]

open access: yes, 2009
Vascular oxidative stress has been shown to be a potent factor in the pathophysiology of endothelial dysfunction. Despite current optimal evidence-based therapy, mortality from various cardiovascular disorders remains high.
Allan Struthers   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy